456MO METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors.
Saved in:
| Title: | 456MO METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors. |
|---|---|
| Authors: | Postel-Vinay, S.1 (AUTHOR), Italiano, A.2 (AUTHOR), Martin Romano, P.3 (AUTHOR), Cassier, P.A.4 (AUTHOR), Siu, L.L.5 (AUTHOR), Lossos, I.S.6 (AUTHOR), Hilton, J.F.7 (AUTHOR), Mckean, M.A.8 (AUTHOR), Strauss, J.9 (AUTHOR), Falchook, G.S.10 (AUTHOR), de Jonge, M.J.A.11 (AUTHOR), Opdam, F.L.12 (AUTHOR), Rasco, D.13 (AUTHOR), Vermaat, J.S.14 (AUTHOR), Crossman, T.15 (AUTHOR), Zajac, M.16 (AUTHOR), Hainline, A.17 (AUTHOR), Kremer, B.18 (AUTHOR), Barbash, O.19 (AUTHOR), Gounder, M.M.20 (AUTHOR) |
| Source: | Annals of Oncology. 2022 Supplement 7, Vol. 33, pS746-S747. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 159077380 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 456MO METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Postel-Vinay%2C+S%2E%22">Postel-Vinay, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Italiano%2C+A%2E%22">Italiano, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Martin+Romano%2C+P%2E%22">Martin Romano, P.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cassier%2C+P%2EA%2E%22">Cassier, P.A.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siu%2C+L%2EL%2E%22">Siu, L.L.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lossos%2C+I%2ES%2E%22">Lossos, I.S.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hilton%2C+J%2EF%2E%22">Hilton, J.F.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mckean%2C+M%2EA%2E%22">Mckean, M.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Strauss%2C+J%2E%22">Strauss, J.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falchook%2C+G%2ES%2E%22">Falchook, G.S.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jonge%2C+M%2EJ%2EA%2E%22">de Jonge, M.J.A.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Opdam%2C+F%2EL%2E%22">Opdam, F.L.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rasco%2C+D%2E%22">Rasco, D.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vermaat%2C+J%2ES%2E%22">Vermaat, J.S.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Crossman%2C+T%2E%22">Crossman, T.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zajac%2C+M%2E%22">Zajac, M.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hainline%2C+A%2E%22">Hainline, A.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kremer%2C+B%2E%22">Kremer, B.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Barbash%2C+O%2E%22">Barbash, O.</searchLink><relatesTo>19</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gounder%2C+M%2EM%2E%22">Gounder, M.M.</searchLink><relatesTo>20</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2022 Supplement 7, Vol. 33, pS746-S747. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=159077380 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2022.07.585 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: S746 Titles: – TitleFull: 456MO METEOR-1: A phase I study of the safety and efficacy of the protein arginine methyltransferase 5 (PRMT5) inhibitor GSK3326595 in advanced solid tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Postel-Vinay, S. – PersonEntity: Name: NameFull: Italiano, A. – PersonEntity: Name: NameFull: Martin Romano, P. – PersonEntity: Name: NameFull: Cassier, P.A. – PersonEntity: Name: NameFull: Siu, L.L. – PersonEntity: Name: NameFull: Lossos, I.S. – PersonEntity: Name: NameFull: Hilton, J.F. – PersonEntity: Name: NameFull: Mckean, M.A. – PersonEntity: Name: NameFull: Strauss, J. – PersonEntity: Name: NameFull: Falchook, G.S. – PersonEntity: Name: NameFull: de Jonge, M.J.A. – PersonEntity: Name: NameFull: Opdam, F.L. – PersonEntity: Name: NameFull: Rasco, D. – PersonEntity: Name: NameFull: Vermaat, J.S. – PersonEntity: Name: NameFull: Crossman, T. – PersonEntity: Name: NameFull: Zajac, M. – PersonEntity: Name: NameFull: Hainline, A. – PersonEntity: Name: NameFull: Kremer, B. – PersonEntity: Name: NameFull: Barbash, O. – PersonEntity: Name: NameFull: Gounder, M.M. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2022 Supplement 7 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
